13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neuroepidemiologists
Neuroepidemiologists study the patterns, causes, and effects of neurological disorders in populations, playing a pivotal role in public health strategies. By analyzing the distribution of conditions like Alzheimer’s, Parkinson’s, and stroke, they identify risk factors and assess disease burden in different demographic groups. Their work aids in understanding the role of genetics, environment, and lifestyle in neurological diseases, guiding preventative measures and public health policies. Using epidemiological methods, they track disease prevalence, incidence, and trends over time, offering valuable insights into emerging health threats. Neuroepidemiologists collaborate with researchers and policymakers to design health interventions, with a focus on high-risk populations. Their research is vital in identifying gaps in current healthcare systems and informing resource allocation. By synthesizing data from global and local studies, they contribute to improving the diagnosis and treatment of neurological conditions. Their work also explores the impact of comorbidities and aging on neurological health, further enhancing preventive strategies. Neuroepidemiologists' role is essential in understanding the evolving landscape of neurological diseases, helping healthcare systems better allocate resources to prevent and manage these disorders.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States